Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Mice with autoimmune hair loss showed signs of heart problems.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Skin tags in obese individuals may indicate higher cardiovascular risk.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Men with male pattern baldness are more likely to have heart disease risk factors, so they should get heart screenings early.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

New drugs for heart disease may be developed from molecules secreted by stem cells.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

In Pakistan, men with more severe hair loss often have a higher BMI.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.